S.Amdt. 374

SA 374. Ms. CORTEZ MASTO (for herself, Ms. Alsobrooks, and Mr. Kim)
submitted an amendment intended to be proposed by her to the concurrent
resolution S. Con. Res. 7, setting forth the congressional budget for
the United States Government for fiscal year 2025 and setting forth the
appropriate budgetary levels for fiscal years 2026 through 2034; which
was ordered to lie on the table; as follows:

At the end of title III, add the following:

SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO LOWERING
PRESCRIPTION DRUG PRICES.

The Chairman of the Committee on the Budget of the Senate
may revise the allocations of a committee or committees,
aggregates, and other appropriate levels in this resolution,
and make adjustments to the pay-as-you-go ledger, for one or
more bills, joint resolutions, amendments, amendments between
the Houses, motions, or conference reports relating to
lowering prescription drug prices, which may include imposing
monetary penalties on drug manufacturers with respect to
prescription drug sales in the commercial market if the
average price of such drugs increases faster than the rate of
inflation or implementing other policies that penalize drug
manufacturers for increasing drug prices faster than
inflation, by the amounts provided in such legislation for
those purposes, provided that such legislation would not
increase the deficit over the period of the total of fiscal
years 2025 through 2034.
______